Article PDF
References
Ingram DV . Ocular effects in long-term amiodarone therapy. Am Heart J 1983;106:902–4.
Rennie IG . Clinically important ocular reactions to systemic drug therapy. Drug Safety 1993;9:196–211.
Kutt H, Winters W, Kokenge R, McDowell F . Diphenylhydantoin metabolism, blood levels and toxicity. Arch Neurol 1964;11:642–8.
Leopold IH . Ocular complications to drugs: visual changes. JAMA 1968;205:631–3.
Weidle EG . Lenticular chrysiasis in oral chrysotherapy. Am J Ophthalmol 1987;103:240–1.
Brookes JG, Matoba AY . Chlorpromazine-induced anterior segment changes. Arch Ophthalmol 1992;110:126.
Bar S, Feller N, Savir H . Presenile cataracts in phenytoin-treated epileptic patients. Arch Ophthalmol 1983;101:422–5.
Kaiser-Kupfer MI, Lippman M . Tamoxifen retino-pathy. Cancer Treat Rep 1978;62:315–20.
McKeown CA, Swartz M, Bolm J, Maggiano JM . Tamoxifen retinopathy. Br J Ophthalmol 1981;65:177–9.
Vinding T, Nielsen NV . Retinopathy caused by treatment with tamoxifen in low dosage. Acta Ophthalmol (Copenh) 1983;61:45–50.
Beck M, Mills PV . Ocular assessment of patients treated with tamoxifen. Cancer Treat Rep 1979;63:1833–4.
Longstaff S, Sigurdsson H, O'Keeffe M, Ogston S, Preece P . A controlled study of the ocular effects of tamoxifen in conventional dosage in the treatment of breast carcinoma. Eur J Cancer Clin Oncol 1989;25:1805–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rennie, I. Of pills and potions. Eye 11, 265–266 (1997). https://doi.org/10.1038/eye.1997.62
Issue Date:
DOI: https://doi.org/10.1038/eye.1997.62